Original-Research: Nabaltec AG - von NuWays AG Einstufung von NuWays AG zu Nabaltec AG Unternehmen: Nabaltec AG ISIN: DE000A0KPPR7 Anlass der Studie: Q3 Review Empfehlung: BUY seit: 24.11.2023 Kursziel: EUR 31,00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Christian Sandherr Q3 review: better-than-feared margin thanks to boehmite; chg Q3 sales decreased by 12% yoy to EUR 49.8m (eNuW: EUR 50.5m) as a result of continued weak end markets, which left a particularly strong mark on the group's Specialty Alumina segment (-24% yoy to EUR 14.1m). Positively, demand for its high-margin product boehmite, which has been weak for more than one year, has begun to pick up.
24.11.2023 - 09:31:39Original-Research: Nabaltec AG (von NuWays AG): BUY
Original-Research: Nabaltec AG - von NuWays AG Einstufung von NuWays AG zu Nabaltec AG Unternehmen: Nabaltec AG ISIN: DE000A0KPPR7 Anlass der Studie: Q3 Review Empfehlung: BUY seit: 24.11.2023 Kursziel: EUR 31,00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Christian Sandherr Q3 review: better-than-feared margin thanks to boehmite; chg Q3 sales decreased by 12% yoy to EUR 49.8m (eNuW: EUR 50.5m) as a result of continued weak end markets, which left a particularly strong mark on the group's Specialty Alumina segment (-24% yoy to EUR 14.1m). Positively, demand for its high-margin product boehmite, which has been weak for more than one year, has begun to pick up. This explains the "only" 6% sales decline of the Functional Fillers segment to EUR 53.7m. In fact, monthly sales volumes should have improved from ~450t to roughly 600t as customers across Eastern Europe are gradually (but slowly) ramping up battery production volumes and Asian customers are slowly reverting back to regular orders. Q3 EBIT came in better than feared at EUR 4.6m (eNuW: EUR 3.4m), a 9.3% margin driven by the improved product mix (higher boehmite and lower Specialty Alumina sales shares) and slightly lower input costs (vs. previous quarters) that compensated for general labour cost inflation. FY guidance confirmed. At the beginning of August, the company adjusted its FY23 guidance to a 4-6% yoy sales decline (eNuW: 5% with an EBIT margin of 6-8% (eNuW new: 7.8%). While we still expect Nabaltec to meet the mid-point of the sales guidance, the upper end of the EBIT margin guidance should be in reach (9M: 8.4% margin), implying a margin of only 5.8% in Q4. Balance sheet remains strong. At the end of Q3, Nabaltec's balance sheet featured roughly EUR 15m net cash (EUR 93m cash, EUR 15m short-term financial assets and EUR 90m debt). During the next 2-3 years, the company looks set to invest roughly EUR 45m into expanding production capacities of boehmite and APYRAL, a gap filler that is mixed with glues used in battery packs/EVs to redirect heat away from the cells. Fully utilized boehmite and APYRAL capacity expansions would yield EUR 65-70m incremental sales and EUR 16m EBIT. What to expect from 2024e. Nabaltec is seen to return to slight growth, thanks to stabilizing sales of core products, environmental friendly flame retardants, and a gradually improving order momentum for boehmite and APYRAL as European EV and battery productions are ramping up. The resulting improvement of the product mix and slight raw material/energy price deflation should allow for further expanding margins. Beyond 2024e, core products should also return to structural growth, in our view. Nabaltec remains a BUY with an unchanged EUR 31 PT, based on FCFY 2024e. Die vollständige Analyse können Sie hier downloaden: http://www.more-ir.de/d/28395.pdf Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden www.nuways-ag.com/research. Kontakt für Rückfragen NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++ -------------------übermittelt durch die EQS Group AG.------------------- Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
